Cytosorbents Crp Stock Performance

CTSO Stock  USD 0.66  0.02  2.94%   
The firm shows a Beta (market volatility) of 0.89, which signifies possible diversification benefits within a given portfolio. Cytosorbents Crp returns are very sensitive to returns on the market. As the market goes up or down, Cytosorbents Crp is expected to follow. At this point, Cytosorbents Crp has a negative expected return of -0.14%. Please make sure to confirm Cytosorbents Crp's treynor ratio, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if Cytosorbents Crp performance from the past will be repeated at some point in the near future.

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Cytosorbents Crp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors. ...more
Last Split Factor
1:25
Last Split Date
2014-12-05
1
CytoSorbents to Participate at the Jefferies Global Healthcare Conference in London
11/11/2025
2
CytoSorbents Reports Third Quarter 2025 Financial Results and Provides Business Update
11/13/2025
3
CytoSorbents Corp Q3 2025 Earnings Call Highlights Record Revenue Growth and Strategic ...
11/14/2025
4
Updated CytoSorbents to Present at the Jefferies Global Healthcare Conference in London
11/17/2025
5
Acquisition by Chan Phillip P. of 100000 shares of Cytosorbents Crp at 0.64 subject to Rule 16b-3
11/18/2025
6
Acquisition by Mariani Peter J of 11363 shares of Cytosorbents Crp at 0.8891 subject to Rule 16b-3
11/28/2025
7
CytoSorbents to Participate in a Virtual Fireside Chat with D. Boral Capital on Monday, December 15, 2025
12/10/2025
8
Does Cytosorbents Corporation stock trade at a discount to peers - Earnings Risk Report Consistent Profit Trade Alerts - ulpravda.ru
01/08/2026
9
CTSO CytoSorbents Price Target Increased to 5.00 Based on Higher Than Expected Gross Margins
01/13/2026
Begin Period Cash Flow15.6 M
Total Cashflows From Investing Activities-669.4 K

Cytosorbents Crp Relative Risk vs. Return Landscape

If you would invest  78.00  in Cytosorbents Crp on November 1, 2025 and sell it today you would lose (12.00) from holding Cytosorbents Crp or give up 15.38% of portfolio value over 90 days. Cytosorbents Crp is currently does not generate positive expected returns and assumes 5.484% risk (volatility on return distribution) over the 90 days horizon. In different words, 49% of stocks are less volatile than Cytosorbents, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days Cytosorbents Crp is expected to under-perform the market. In addition to that, the company is 7.3 times more volatile than its market benchmark. It trades about -0.02 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.08 per unit of volatility.

Cytosorbents Crp Target Price Odds to finish over Current Price

The tendency of Cytosorbents Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 0.66 90 days 0.66 
about 79.69
Based on a normal probability distribution, the odds of Cytosorbents Crp to move above the current price in 90 days from now is about 79.69 (This Cytosorbents Crp probability density function shows the probability of Cytosorbents Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Cytosorbents Crp has a beta of 0.89 suggesting Cytosorbents Crp market returns are highly reactive to returns on the market. As the market goes up or down, Cytosorbents Crp is expected to follow. Additionally Cytosorbents Crp has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   Cytosorbents Crp Price Density   
       Price  

Predictive Modules for Cytosorbents Crp

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Cytosorbents Crp. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Cytosorbents Crp's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.030.666.11
Details
Intrinsic
Valuation
LowRealHigh
0.030.586.03
Details
Naive
Forecast
LowNextHigh
0.010.596.04
Details
2 Analysts
Consensus
LowTargetHigh
4.785.255.83
Details

Cytosorbents Crp Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Cytosorbents Crp is not an exception. The market had few large corrections towards the Cytosorbents Crp's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Cytosorbents Crp, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Cytosorbents Crp within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-0.3
β
Beta against Dow Jones0.89
σ
Overall volatility
0.06
Ir
Information ratio -0.06

Cytosorbents Crp Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Cytosorbents Crp for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Cytosorbents Crp can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Cytosorbents Crp generated a negative expected return over the last 90 days
Cytosorbents Crp has high historical volatility and very poor performance
Cytosorbents Crp has some characteristics of a very speculative penny stock
Cytosorbents Crp has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 35.59 M. Net Loss for the year was (20.72 M) with profit before overhead, payroll, taxes, and interest of 26.18 M.
Cytosorbents Crp currently holds about 30.16 M in cash with (14.43 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.69, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Roughly 16.0% of the company shares are held by company insiders
Latest headline from finance.yahoo.com: New Jerseys Emerging Medtech Ecosystem Showcased Through Edge Medical Ventures Event at Liberty Science Center

Cytosorbents Crp Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Cytosorbents Stock often depends not only on the future outlook of the current and potential Cytosorbents Crp's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Cytosorbents Crp's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding54.4 M
Cash And Short Term Investments3.3 M

Cytosorbents Crp Fundamentals Growth

Cytosorbents Stock prices reflect investors' perceptions of the future prospects and financial health of Cytosorbents Crp, and Cytosorbents Crp fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Cytosorbents Stock performance.

About Cytosorbents Crp Performance

By examining Cytosorbents Crp's fundamental ratios, stakeholders can obtain critical insights into Cytosorbents Crp's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Cytosorbents Crp is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Last ReportedProjected for Next Year
Days Of Inventory On Hand 109.58  104.10 
Return On Tangible Assets(0.43)(0.45)
Return On Capital Employed(0.51)(0.49)
Return On Assets(0.39)(0.41)
Return On Equity(2.15)(2.04)

Things to note about Cytosorbents Crp performance evaluation

Checking the ongoing alerts about Cytosorbents Crp for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Cytosorbents Crp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Cytosorbents Crp generated a negative expected return over the last 90 days
Cytosorbents Crp has high historical volatility and very poor performance
Cytosorbents Crp has some characteristics of a very speculative penny stock
Cytosorbents Crp has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 35.59 M. Net Loss for the year was (20.72 M) with profit before overhead, payroll, taxes, and interest of 26.18 M.
Cytosorbents Crp currently holds about 30.16 M in cash with (14.43 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.69, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Roughly 16.0% of the company shares are held by company insiders
Latest headline from finance.yahoo.com: New Jerseys Emerging Medtech Ecosystem Showcased Through Edge Medical Ventures Event at Liberty Science Center
Evaluating Cytosorbents Crp's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Cytosorbents Crp's stock performance include:
  • Analyzing Cytosorbents Crp's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Cytosorbents Crp's stock is overvalued or undervalued compared to its peers.
  • Examining Cytosorbents Crp's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Cytosorbents Crp's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Cytosorbents Crp's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Cytosorbents Crp's stock. These opinions can provide insight into Cytosorbents Crp's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Cytosorbents Crp's stock performance is not an exact science, and many factors can impact Cytosorbents Crp's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
When determining whether Cytosorbents Crp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cytosorbents Crp's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cytosorbents Crp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cytosorbents Crp Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cytosorbents Crp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
To learn how to invest in Cytosorbents Stock, please use our How to Invest in Cytosorbents Crp guide.
You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Will Health Care Equipment & Supplies sector continue expanding? Could Cytosorbents diversify its offerings? Factors like these will boost the valuation of Cytosorbents Crp. Projected growth potential of Cytosorbents fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Cytosorbents Crp data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(0.18)
Revenue Per Share
0.614
Quarterly Revenue Growth
0.101
Return On Assets
(0.19)
Return On Equity
(0.93)
Investors evaluate Cytosorbents Crp using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Cytosorbents Crp's intrinsic value—the estimated true worth—helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Cytosorbents Crp's market price to deviate significantly from intrinsic value.
It's important to distinguish between Cytosorbents Crp's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Cytosorbents Crp should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Cytosorbents Crp's market price signifies the transaction level at which participants voluntarily complete trades.